Insiders who reported open-market trades in the last 12 months at the companies Miriam Kidron files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Joshua Hexter - $747K in ORMP purchases and sales in the last 12 months
Avraham Gabay - $421K in ORMP purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Miriam Kidron is a corporate insider, tracked as Chief Scientific Officer, Director of ORAMED PHARMACEUTICALS INC. (ORMP). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Miriam Kidron submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Miriam Kidron is Chief Scientific Officer, Director of ORAMED PHARMACEUTICALS INC. (ORMP). 8 SEC Form 4 filings on record going back to 2024, most recently on 25 September 2026.
Recent transactions
10
The latest 10 SEC Form 4 transactions reported by Miriam Kidron.
InsiderAlpha's records for Miriam Kidron go back to 2024: 8 primary Form 4 filings, an average of 2.7 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
